CDC, FDA Evaluating Next Steps:
NYS cooperates with J&J vaccine hold
As you may have read, today the CDC and the FDA issued a statement recommending a pause in the use of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution.
New York State will follow the CDC and FDA recommendation and pause the use of the J&J vaccine statewide while the federal government evaluates next steps. As the CDC and FDA stated, these adverse events "appear to be extremely rare." Six people who have received the J&J vaccine in the U.S. developed blood clots, and the reason for the pause is to make sure all health care providers can identify the symptoms and treat patients with the correct medical protocol.
The context, however — six people reported with a problem out of 6.8 million who received the vaccine — is important to remember. While health care providers are notified and the federal government reviews the situation fully, New York State will continue to administer the Pfizer and Moderna vaccines, which are completely unaffected by this pause and which make up the vast majority of our supply. The State Department of Health is in constant contact with the federal government and will provide updates.